The study is primarily aimed to collect further data on the safety of the investigational product in a large patient population when used in routine clinical practice in the Asian-Pacific region.
Study Type
OBSERVATIONAL
Enrollment
1,000
Venofundin 6% / Tetraspan 6%
Xuzhou Central Hospital
Xuzhou, Jiangsu, China
Jiangsu Province Hospital
Nanjing, Jiangsu Province, China
The Sixth Hospital of Shanghai
Shanghai, China
The First Hospital of Shanghai
Shanghai, China
number of adverse drug reactions
Time frame: up to 48 hours
change in haemodynamics during surgery or intensive care unit stay
Time frame: up to 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dong Fang Gan Dan Hospital of Shanghai
Shanghai, China
Hospital Kuala Lumpur
Kuala Lumpur, Malaysia, Malaysia